Related Experiment Video

Updated: Jun 7, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.9K

Emerging strategies to overcome ovarian cancer: advances in immunotherapy

Tatiana Massariol Pimenta1, Josiany Carlos de Souza2, Bárbara da Silva Martins1

  • 1Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil.

Frontiers in Pharmacology
|November 20, 2024
PubMed

Insights

Ovarian cancer immunotherapy offers a promising alternative to traditional treatments due to late diagnoses and chemoresistance. Ongoing research explores advancements in cancer vaccines and cell therapies to improve patient outcomes.

Area of Science:

  • Gynecologic Oncology
  • Immunology
  • Cancer Research

Background:

  • Ovarian cancer is a leading cause of cancer death in women globally.
  • Late diagnosis and chemoresistance contribute to poor prognosis.
  • Current treatments necessitate novel therapeutic strategies.

Purpose of the Study:

  • To explore immunotherapy as a promising treatment for ovarian cancer.
  • To review current advancements in immunotherapeutic approaches for ovarian cancer.
  • To highlight the potential of immunotherapy in overcoming treatment resistance.

Main Methods:

  • Review of current literature on ovarian cancer immunotherapy.
  • Analysis of ongoing research in cancer vaccines, immune checkpoint blockade, and CAR-T cell therapy.
  • Synthesis of data on the mechanisms of anti-tumor immune response.

Main Results:

  • Immunotherapy stimulates anti-tumor immunity and immunological memory.
  • Strategies like cancer vaccines and CAR-T cells show potential.
  • Immune checkpoint blockade offers a novel therapeutic avenue.

Conclusions:

  • Immunotherapy presents a viable alternative for ovarian cancer treatment.
  • Further research into novel immunotherapeutic strategies is crucial.
  • Harnessing the immune system can combat advanced-stage ovarian cancer and recurrence.
Keywords:
CAR-T cell therapyantibody therapycancer vaccinesimmunotherapyovarian cancer

More Related Videos

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-107:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

2.5K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.6K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849